Profile
DXR ISRG BDX ALC BDXA RMD
Company Name Daxor Corporation Intuitive Surgical, Inc. Becton, Dickinson and Company Alcon Inc. Becton, Dickinson and Company ResMed Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies
Market Cap $36.42M $189.75B $48.46B $48.16B $47.95B $35.18B
Employees 0.04K 15.64K 70.00K 25.60K 0.00K 9.98K
CEO Mr. Michael Richard Feldschuh Dr. Gary S. Guthart Ph.D. Mr. Thomas E. Polen Jr. Mr. David J. Endicott - Mr. Michael J. Farrell BE, MBA, SM
Ratings
DXR ISRG BDX ALC BDXA RMD
Quant Rating Score 2 3 3 3 5 4
Quant Rating Sell Neutral Neutral Neutral Strong Buy Buy
Trading
DXR ISRG BDX ALC BDXA RMD
Last Close $7.7 $538.16 $167.95 $95.88 $59.24 $243.09
High 52 $9.89 $610.45 $249.08 $100.76 $59.24 $257.65
Low 52 $7.05 $380.88 $165.15 $80.92 $59.24 $182.2
Price vs. 52 Week High -22.14 % -11.84 % -32.57 % -4.84 % 0 % -5.65 %
Price vs. 52 Week Low 9.22 % 41.29 % 1.7 % 18.49 % 0 % 33.42 %
Total Return
DXR ISRG BDX ALC BDXA RMD
1 Month Return -0.17 % 2.94 % -19.78 % 6.62 % 0 % 12.29 %
3 Month Return 1.99 % -7.89 % -26.93 % 7.04 % 0 % 2.6 %
6 Month Return -18.69 % 0.32 % -27.5 % 3.53 % 0 % -3.68 %
9 Month Return -12.5 % 16.13 % -28.8 % 3.19 % 0 % 12.24 %
YTD Return 0.13 % 3.1 % -25.97 % 12.95 % 0 % 6.3 %
1 Year Return -20.4 % 39.62 % -28.53 % 17.7 % 0 % 12.11 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
DXR ISRG BDX ALC BDXA RMD
Dividend Yield Percentage (TTM) - - 2.36 % 0.27 % 2.37 % 0.86 %
Dividend Paid and Capex Coverage Ration (TTM) -465343.67 % 2.77 % 1.77 % 3.17 % 1.77 % 4.21 %
Dividend Per Share (TTM) - - 3.98 % 0.26 % 3.98 % 2.07 %
Payout Ratio (TTM) - - 76.77 % 12.35 % 76.77 % 23.14 %
Profitability
DXR ISRG BDX ALC BDXA RMD
Gross Profit Margin TTM 90.27 % 67.09 % 44.5 % 55.61 % 44.5 % 58.53 %
Return on Assets TTM 1.46 % 12.88 % 2.75 % 3.35 % 2.75 % 17.36 %
Return on Equity TTM 1.57 % 15.52 % 5.86 % 6.43 % 5.86 % 25.18 %
Return on Capital Employed TTM 5.21 % 13.9 % 5.05 % 5.03 % 5.05 % 24.33 %
Net Income Per EBT TTM -49 % 88.31 % 89.01 % 81.05 % 89.01 % 83.26 %
EBT Per Ebit TTM -57.37 % 114.09 % 71.19 % 88.89 % 71.19 % 97.84 %
EBIT Per Revenue TTM 248.71 % 28.2 % 11.33 % 14.24 % 11.33 % 32.1 %
Cash Flow To Debt Ratio TTM - - 17.12 % 40.08 % 17.12 % 196.83 %
Receivables Turnover TTM 79.26 7.13 6.89 4.77 6.89 5.53
Payables Turnover TTM - 10.39 - 5.7 - 9.36
Inventory Turnover TTM - 1.85 3.11 1.94 3.11 2.41
Fixed Asset Turnover TTM - 181.6 % 313.98 % 205.17 % 313.98 % 729.93 %
Asset Turnover TTM 2.09 % 45.34 % 38.31 % 32.71 % 38.31 % 66.36 %
Operating Cash Flow Per Share TTM -0.28 7.64 11.44 4.16 11.44 11.27
Free Cash Flow Per Share TTM -0.28 4.88 8.98 3.1 8.98 10.66
Cash Per Share TTM - 1261.9 % 236.81 % 370.15 % 236.81 % 635.71 %
Operating Cash Flow Sales Ratio TTM -182 % 31.34 % 15.81 % 20.74 % 15.81 % 32.92 %
Free Cash Flow Operating Cash Flow Ratio TTM 100 % 63.9 % 78.51 % 74.53 % 78.51 % 94.64 %
Cash Flow Coverage Ratios TTM - - 17.12 % 40.08 % 17.12 % 196.83 %
Price To Free Cash Flows Ratio TTM -26.09 108.72 18.71 31.39 18.59 22.49
Price To Operating Cash Flows Ratio TTM -26.61 69.3 14.76 23.39 14.68 21.3
Price Cash Flow Ratio TTM -26.61 69.3 14.76 23.39 14.68 21.3
Income Statement (TTM)
DXR ISRG BDX ALC BDXA RMD
Revenue $0B $8.35B $20.18B $9.91B $20.18B $4.69B
Gross Profit $0B $5.63B $9.13B $5.51B $9.13B $2.66B
Gross Profit Ratio 100% 67.46% 45.22% 55.61% 45.22% 56.67%
EBITDA $0B $2.67B $4.82B $2.68B $4.82B $1.53B
Net Income $0B $2.32B $1.71B $1.02B $1.71B $1.02B
EPS Diluted 0.11 6.42 5.86 2.05 5.86 6.92
Balance Sheet (MRQ)
DXR ISRG BDX ALC BDXA RMD
Long Term Debt $0B $0B $17.94B $4.97B $17.94B $0.84B
Total Liabilities $0B $2.21B $31.4B $8.79B $31.4B $2.01B
Total Equity $0.04B $16.53B $25.89B $21.55B $25.89B $4.86B
Total Investments $0.04B $6.81B $0.45B $0.75B $0.45B $0.17B
Total Debt $0B $0B $20.11B $5.14B $20.11B $0.87B
Total Assets $0.04B $18.74B $57.29B $30.35B $57.29B $6.87B
Cash Flow Statement (TTM)
DXR ISRG BDX ALC BDXA RMD
Net Income $0B $2.34B $1.71B $1.02B $1.71B $1.02B
Inventory $0B $-0.83B $0.1B $-0.05B $0.1B $0.17B
Dividends Paid $0B $0B $-1.1B $-0.13B $-1.1B $-0.28B
Operating Cash Flow $0B $2.42B $3.8B $2.08B $3.8B $1.4B
Capital Expenditure $0B $-1.11B $-0.73B $-0.67B $-0.73B $-0.11B
Related Stocks
Ticker Name Price
AKYA Akoya Biosciences, Inc. 1.12
ALC Alcon Inc. 96.365
ANGO AngioDynamics, Inc. 9.24
APR Apria, Inc. 37.5
ATR AptarGroup, Inc. 153.86
ATRC AtriCure, Inc. 31.155
ATRI Atrion Corporation 459.92
ATRS Antares Pharma, Inc. 5.59
AVGR Avinger, Inc. 0.474
AZTA Azenta, Inc. 27.19
BAX Baxter International Inc. 31.325
BDX Becton, Dickinson and Company 169.09
BDXA Becton, Dickinson and Company 59.24
BDXB Becton, Dickinson and Company 48.16
BLCO Bausch + Lomb Corporation 11.34
BLFS BioLife Solutions, Inc. 24.09
COO The Cooper Companies, Inc. 82.76
EKSO Ekso Bionics Holdings, Inc. 0.42
FEMY Femasys Inc. 1.07
GCTK GlucoTrack, Inc. 0.16
ETFs With Exposure to DXR
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0 278.422
VTSAX Vanguard Total Stock Market Index Fund 0 135.4
VITSX Vanguard Total Stock Market Index Fund 0 135.42
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0 254.04
Unlock